亚宝药业：累计斥资5215.19万元回购1.14%股份

Core Viewpoint - The company plans to repurchase shares starting from May 16, 2025, with an estimated amount of 50 million to 100 million yuan aimed at reducing registered capital [1] Group 1 - As of October 31, the company has repurchased a total of 8 million shares, accounting for 1.14% of the total share capital [1] - The total amount paid for the repurchased shares is 52.1519 million yuan, with a repurchase price range of 6.30 yuan to 6.65 yuan per share [1] - The company will implement the repurchase at its discretion during the repurchase period and will disclose progress in a timely manner [1]